Editas Medicine Q2 Net Income USD -18.23 Million Vs. IBES Estimate USD -27 Million
EDIT•Second-quarter results
- Aug. 05 (Reuters) - Editas Medicine Q2 operating expenses USD 30.444 million.
- Q2 operating income USD -18.554 million
- Q2 basic EPS USD -0.15
- Q2 collaboration and other research and development revenue USD 11.9 million
- Q2 EPS USD -0.15
